Baccardax, a former bond salesman who spent 8 years on the trading floor in Toronto and London, has worked in and around the global financial markets for more than 25 years, covering companies from birth in the bond markets to death in the bankruptcy courts -- and all points in between.
Following television stints with CNBC Europe in London, where he served as on-air Economics editor co-anchor of the Closing Bell program, Baccardax was named London Bureau Chief in October 2016.
Global stocks extended gains Thursday amid multiple reports of significant progress in U.S.-China trade talks and confirmation from the Federal Reserve that it will remain "patient" on future rate hikes in the world's biggest economy.
Danske Bank shares traded sharply lower Thursday after the Nordic lender said it was in active discussions with the U.S. Department of Justice amid a criminal investigation into allegations of money laundering at one of its branches in Estonia.
Barclays shares traded at the top of the London market Thursday after Britain's second-biggest bank posted weaker-than-expected full year earnings but said it would increase investor returns this year as it faces increasing pressure from activists to boost its bottom line.
CVS Health trades sharply lower Wednesday after it posts stronger-than-expected fourth-quarter earnings but issues 2019 profit guidance that falls far short of Wall Street forecasts.
Owens Corning posted stronger-than-expected fourth quarter profits Wednesday and said it sees returning to a "strong conversion of adjusted earnings into free cash flow" over the coming year.
Merck shares slipped lower in pre-market trading Wednesday after the drugmaker said one of its key liver cancer treatments failed a late-stage trial only months after getting accelerated approval from the U.S. Food & Drug Administration.
The U.S. dollar held onto gains against its global peers Wednesday ahead of Minutes from the Federal Reserve that are expected to confirm the bank's recent signals on slower rate hikes and a more patient approach to monetary policy in the face of uncertain economic growth at home and notable weakening around the world.
Teva Pharmaceuticals shares were indicated lower in pre-market trading Wednesday after the drugmaker reached a settlement with the Federal Trade Commission over allegations it delayed the release of generic medicines through agreements with pharmaceutical rivals.
Walmart struggling U.K. subsidiary could be blocked from merging with a larger rival over concerns from the country's competition watchdog that the tie-up would lead to higher prices and a "poorer experience" for shoppers in Europe's second-largest market.
Global stocks traded cautiously higher again Wednesday, with markets in Asia touching fresh four-month highs, amid increasing signs of tangible progress in U.S.-China trade talks and a suggestion from President Donald Trump that negotiations could be extended if the two sides fail to reach an agreement by the first of next month.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.